Clonazepam Tablet
Product Images NDC 71610-790

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 71610-790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 0.5 mg (71610 0790 15)

Bottle Label 0.5 mg (71610 0790 15)
Clonazepam 0.5 mg oral tablet bottle label showing the drug name, NDC 71610-0790-15, and quantity of 15 tablets. The label includes storage instructions (store between 20-25°C), handling warnings (avoid light, moisture, and children), manufacturer information as Rubicon Research Private Limited, Ambernath, India, and distributor Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. It also notes controlled substance status (C-IV) and a habit-forming warning.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Image (Clonazepam Tablets C Iv Structure)

FDA Label Image

Image Description (Clonazepam Tablets Imprint Image)

Image Description (Clonazepam Tablets Imprint Image)
Clonazepam 0.5 mg tablet imprints shown with a unique marking including a triangle over the number 66 on one side and a score line on the other. The image also indicates that Clonazepam tablets come in 1 mg and 2 mg strengths with different embossments, including a triangle over the number 67 and 69 respectively, and unique scoring or blank faces for each strength. The tablets are round and scored or plain on one side.*
FDA Label Image

Image Description (Clonazepam Tablets Structure)

Image Description (Clonazepam Tablets Structure)
Chemical structure of clonazepam, illustrating the molecular framework including a nitro group, a chlorophenyl group, and a diazepine ring system as part of the compound's structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.